Six generations of a Japanese family had gouty arthritis and progressive nephropathy. Data on nine of 51 women (18%) and 15 of 66 men (23%) with either asymptomatic hyperuricaemia, gouty arthritis, or renal insufficiency were obtained. Renal function in four men and one woman with hyperuricaemia or gouty arthritis was also examined. Urinary excretion of uric acid was decreased in all subjects examined, including the young.
men and one woman with hyperuricaemia or gouty arthritis was also examined. Urinary excretion of uric acid was decreased in all subjects examined, including the young. Erythrocyte phosphoribosylpyrophosphate synthetase and hypoxanthine-guanine phosphoribosyltransferase activities determined in 10 patients were normal. Some patients had been treated with aliopurinol to reduce serum uric acid concentrations, but the treatment did not prevent progression of renal impairment. Transmission of the disease in this large family is considered to be autosomal dominant. The data suggest that the disease in this family is the same entity as that described by other workers-that is, familial urate nephropathy. As far as is known this is the largest family with this disease so far reported.
Primary gout is a metabolic disease which may be closely linked to nephropathy. As a cause of severe renal impairment, however, it accounts for only a small proportion of all cases. According to a report by the Japanese Society for Dialysis Therapy in 1989, only 0-7% of 80 075 patients undergoing dialysis had gout as a primary disease.' Several articles have described families with gout and renal failure.2-'3 Richmond et al described such a family with 'familial urate nephropathy',2 while Duncan and Dixon reported a similar disease and termed it 'familial gouty nephropathy'.3 Members of these families had marked hyperuricaemia and gout even when young, and their renal function progressively deteriorated. In addition, women commonly had the disease, in sharp contrast with the rare occurrence of gout in women in the general population. In this article we describe the findings in a six generation Japanese family, many of whom had gout and progressive nephropathy; abnormal renal handling of uric acid was found in some members.
Methods

CLEARANCE STUDY
Amounts of uric acid excreted in urine and values of uric acid clearance were determined from 24 hour urine specimens obtained from subjects not receiving a purine restricted diet. The concentrations of serum and urinary uric acid or creatinine were measured by an automatic analyser (TBA-50S, Toshiba, Japan). fig 1) urinary excretion of uric acid was low. It seems that reduced excretion of uric acid is the primary cause of hyperuricaemia in this family.
To exclude the possibility of other causes of genetic hyperuricaemia and gout the activities of hypoxanthine-guanine phosphoribosyltransferase and phosphoribosylpyrophosphate syn- tReceiving ailopurinol 200-300 mg/day. thetase were assayed in the erythrocytes from 10 subjects in this family. There are two major purine metabolising enzymes, genetic abnormalities of which may result in overproduction of uric acid. These enzyme activities were normal, however. These results exclude the possibility of partial deficiency in hypoxanthine-guanine phosphoribosyltransferase and hyperactivity of phosphoribosylpyrophosphate synthetase as the cause of hyperuricaemia. At least four patients were treated with allopurinol 200-300 mg/day. Figure 2 shows the effect of this treatment on serum uric acid and creatinine concentrations. Despite control of serum uric acid concentrations with allopurinol, serum creatinine concentrations gradually increased in all patients, indicating progressive deterioration of renal function.
Discussion
In most chronic diseases serum uric acid concentrations are not greatly increased before renal function is severely impaired because reduction in the amount of uric acid filtered through the glomerulus is well compensated for by increasing tubular excretion of uric acid. '6 Therefore chronic renal insufficiency from primary renal disease is a rare cause of severe hyperuricaemia or gout. On the other hand, impairment of renal function usually develops only at a later stage of primary gout unless hypertension or renal calculi occur. '7 18 It is also rare, therefore, that young subjects develop severe renal impairment because of primary gout.
The cause of the familial disease described here could be explained neither by renal insufficiency secondary to usual primary gout, nor by gout/hyperuricaemia secondary to the usual renal disease. Early onset of hyperuricaemia and gout followed by rapid development of renal impairment is a characteristic feature of this familial disease. Strict control of hyperuricaemia with allopurinol in some family members prevented gouty arthritis, but not the progression of renal impairment, indicating that hyperuricaemia is not the primary cause of this renal disease. The mechanism causing hyperuricaemia seems to be a marked reduction in urinary excretion of uric acid.
Another characteristic of this familial disease is a high rate of association with hypertension, even in those without marked renal insufficiency. Thus seven out of 14 patients with this renal disease or gouty arthritis (or both) had hypertension. One member (V-3 in fig 1) 
